News
Important Only
Other
Tech Mahindra Unveils 'AI Delivered Right' A Comprehensive Strategy To Help Enterprises Scale Ai With Purpose And Precision
April 24 (Reuters) - Tech Mahindra Ltd TEML.NS:TECH MAHINDRA UNVEILS 'AI DELIVERED RIGHT': A COMPREHENSIVE STRATEGY TO HELP ENTERPRISES SCALE AI WITH PURPOSE AND PRECISIONReuters
Thu, Apr 24
Other
Autodesk Announces Appointment Of Two Independent Directors
April 24 (Reuters) - Autodesk Inc ADSK.O:AUTODESK ANNOUNCES APPOINTMENT OF TWO INDEPENDENT DIRECTORSAUTODESK INC - TO APPOINT JEFF EPSTEIN AND CHRISTIE SIMONS TO BOARDAUTODESK INC: AUTODESK AND STARBOARD ENTER INTO COOPERATION AGREEMENTAUTODESK INC - STARBOARD TO WITHDRAW DIRECTOR NOMINEES UNDER COO...Reuters
Thu, Apr 24
Other
United Invests In Next Generation Blended Wing Aircraft Start-Up JetZero
April 24 (Reuters) - United Airlines Holdings Inc UAL.O:UNITED INVESTS IN NEXT GENERATION BLENDED WING AIRCRAFT START-UP JETZEROUNITED AIRLINES HOLDINGS INC - HAS OPTION TO PURCHASE UP TO 200 JETZERO AIRPLANESReuters
Thu, Apr 24
Other
Red Robin Gourmet Burgers Announces Leadership Transition
April 24 (Reuters) - Red Robin Gourmet Burgers Inc RRGB.O:RED ROBIN GOURMET BURGERS, INC. ANNOUNCES LEADERSHIP TRANSITIONRED ROBIN GOURMET BURGERS INC - G.J. HART TO STEP DOWN AS PRESIDENT AND CEORED ROBIN GOURMET BURGERS INC - DAVID A. PACE APPOINTED AS PRESIDENT AND CEORED ROBIN GOURMET BURGERS- E...Reuters
Thu, Apr 24
Other
Arkion Wins Multi-Year Deal With Energisa For Comprehensive Grid Condition Assessments
April 24 (Reuters) - Energisa SA ENGI11.SA:ARKION: WINS MULTI-YEAR DEAL WITH ENERGISA FOR COMPREHENSIVE GRID CONDITION ASSESSMENTSARKION: OVER A 3-YEAR PERIOD, WILL DELIVER CONDITION ASSESSMENTS FOR 2.5 MILLION TRANSMISSION & DISTRIBUTION STRUCTURES FOR ENERGISAReuters
Thu, Apr 24
Other
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission Of IND For A Phase 2 Clinical Trial For EL-22 In Combination With GLP-1 Receptor Agonist For Obesity Treatment
April 24 (Reuters) - PMGC Holdings Inc ELAB.O:NORTHSTRIVE BIOSCIENCES ANNOUNCES POSITIVE FDA RESPONSE SUPPORTING A SUBMISSION OF IND FOR A PHASE 2 CLINICAL TRIAL FOR EL-22 IN COMBINATION WITH GLP-1 RECEPTOR AGONIST FOR OBESITY TREATMENTPMGC HOLDINGS INC - NORTHSTRIVE TO FILE IND APPLICATION IN 2025Reuters
Thu, Apr 24
Stocks
PRESS DIGEST-Canada - April 24
April 24 (Reuters) - The following are the top stories from Canadian newspaper The Globe and Mail. Reuters has not verified these stories and does not vouch for their accuracy.THE GLOBE AND MAIL- Hudson's Bay Co. will begin clearance sales at six stores previously excluded from liquidation, as t...Reuters
Thu, Apr 24
Other
Integer Announces CEO Succession Plan
April 24 (Reuters) - Integer Holdings Corp ITGR.N:INTEGER ANNOUNCES CEO SUCCESSION PLANINTEGER HOLDINGS CORP - JOSEPH DZIEDZIC TO RETIRE AS PRESIDENT AND CEO EFFECTIVE OCT 24, 2025INTEGER HOLDINGS CORP - PAYMAN KHALES APPOINTED PRESIDENT AND CEO EFFECTIVE OCT 24, 2025Reuters
Thu, Apr 24
Other
Coya Therapeutics Announces Positive Interim Results Of An Investigator-Initiated Open Label Study With Low-Dose IL-2 And CTLA4-Ig Combination Treatment In Five Patients With Mild To Moderate Frontotemporal Dementia
April 24 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES POSITIVE INTERIM RESULTS OF AN INVESTIGATOR-INITIATED OPEN LABEL STUDY WITH LOW-DOSE IL-2 AND CTLA4-IG COMBINATION TREATMENT IN FIVE PATIENTS WITH MILD TO MODERATE FRONTOTEMPORAL DEMENTIACOYA THERAPEUTICS INC - STUDY SHOWS...Reuters
Thu, Apr 24
Stocks
Dover falls after cutting annual profit forecast
** Industrial parts maker Dover's DOV.N shares fall 3.8% to $160 premarket after co cut full-year adj profit forecast** DOV lowered full-year adjusted profit range to $9.20 per share to $9.40 per share, compared with $9.30 per share to $9.50 per share expected previously ** Co posted Q1 adj EPS ...Reuters
Thu, Apr 24
Other
NCI-Sponsored Study Shows Positive Data For Lucid Diagnostics' Esoguard® Esophageal Dna Test In Patients Without Symptomatic Gerd
April 24 (Reuters) - Lucid Group Inc LCID.O:NCI-SPONSORED STUDY SHOWS POSITIVE DATA FOR LUCID DIAGNOSTICS' ESOGUARD® ESOPHAGEAL DNA TEST IN PATIENTS WITHOUT SYMPTOMATIC GERDReuters
Thu, Apr 24
Other
Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
April 24 (Reuters) - Guardant Health Inc GH.O:GUARDANT HEALTH ANNOUNCES STRATEGIC COLLABORATION WITH PFIZER TO SUPPORT DEVELOPMENT AND COMMERCIALIZATION OF NEW CANCER THERAPIES USING GUARDANT INFINITY SMART LIQUID BIOPSY PLATFORMGUARDANT HEALTH INC - COLLABORATION PROVIDES PFIZER ACCESS TO GUARDANT ...Reuters
Thu, Apr 24
Other
Imaflex Reports Q4 And FY 2024 Results Provides Business Update
April 24 (Reuters) - Imaflex Inc IFX.V:IMAFLEX REPORTS Q4 AND FY 2024 RESULTS; PROVIDES BUSINESS UPDATEIMAFLEX - Q4 BASIC EPS CAD 0.01IMAFLEX - Q4 REVENUE CAD 25.2 MILLIONIMAFLEX - REMAINS CONFIDENT TO NAVIGATE CURRENT ECONOMIC ENVIRONMENTReuters
Thu, Apr 24
